Angina Pectoris Dr. Shariq Syed

Similar documents
Angina Pectoris. Edward JN Ishac, Ph.D. Smith Building, Room

Pharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

Drug Treatment of Ischemic Heart Disease

Drug Treatment of Ischemic Heart Disease

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

DRUGS USED IN ANGINA PECTORIS

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Antianginal Drugs 18 I. OVERVIEW II. TYPES OF ANGINA

Treatment of T Angina reatment of By Ali Alalawi

Pharmacotherapy of Angina Pectoris

Nitroglycerin and Heparin Drip Interfacility Protocols

Pharmacotherapy of Angina Pectoris

Chapter (9) Calcium Antagonists

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Heart Failure (HF) Treatment

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Coronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Cardiac Emergencies. A Review of Cardiac Compromise. Lawrence L. Lambert

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Drug Treatment of Ischemic Heart Disease

CHAPTER-I MYOCARDIAL INFARCTION

Arrhythmias. Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium.

Structure and organization of blood vessels

Antianginal Drugs. Garrett J. Gross THE THERAPEUTIC OBJECTIVES IN THE USE OF ANTIANGINAL DRUGS

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

EMT. Chapter 14 Review

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

Initial Medical and Surgical Management of Unstable Angina Pectoris

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

ANTIANGINAL AGENTS AND VASODILATORS (1)

Objectives: This presentation will help you to:

Arrhythmias. 1. beat too slowly (sinus bradycardia). Like in heart block

EKG Competency for Agency

New Zealand Data Sheet. LYCINATE Sublingual Tablets contain 0.6mg (600mcg) glyceryl trinitrate.

Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart

Section 3, Lecture 2

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

TELEMETRY EXAM. 1. Match the numeral in the right column with the correct drug in the left column. a. Pronestyl 1. Hypotension

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O.

WHAT DO YOU SEE WHEN YOU STIMULATE BETA

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

PRODUCT INFORMATION ISORDIL ORAL AND SUBLINGUAL TABLETS

Managing Hypertension in the Perioperative Arena

Adenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Chapter 11. The Cardiovascular System. Clicker Questions Pearson Education, Inc.

The Cardiovascular System

Pyruvate + NADH + H + ==== Lactate + NAD +

Acute coronary syndromes

MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient

B-blockers. Effects not related to Beta-Blockade

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Mr. Eknath Kole M.S. Pharm (NIPER Mohali)

ANTI - ARRHYTHMIC DRUGS

Ischemic Heart Disease

Hypertension (JNC-8)

Cardiovascular drugs

Month/Year of Review: November 2014 Date of Last Review: June 2012 PDL Classes: Anti-anginals, Cardiovascular

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

Dr. Vishaal Bhat. anti-adrenergic drugs

Results of Ischemic Heart Disease

Ischemic heart disease

Fundamentals of Pharmacology for Veterinary Technicians Chapter 8

Hypertension. Penny Mosley MRPharmS

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Cardiac Emergencies. Jim Bennett Paramedic and Clinical Education Coordinator American Medical Response Spokane, Washington

Managing IHD and acute Myocardial Infarction

Collin County Community College. ! BIOL Anatomy & Physiology! WEEK 5. The Heart

Chapter 9, Part 2. Cardiocirculatory Adjustments to Exercise

7/21/2017. Learning Objectives. Current Cardiovascular Pharmacology. Epinephrine. Cardiotonic Agents. Epinephrine. Epinephrine. Arthur Jones, EdD, RRT

Chapter 03: Sinus Mechanisms Test Bank MULTIPLE CHOICE

Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris

Nothing to Disclose. Severe Pulmonary Hypertension

METOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

Make you feel better Make you live longer

Drug Profiles Professional Responder

MYOCARDIALINFARCTION. By: Kendra Fischer

Cardiovascular System Notes: Heart Disease & Disorders

Hypertensives Emergency and Urgency

The Heart. Happy Friday! #takeoutyournotes #testnotgradedyet

Dysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

P-RMS: IE/H/PSUR/0014/002

Electrical Conduction

Objectives. Pharmacological Management of Chronic Coronary Artery Disease. Epidemiology

Severe Coronary Vasospasm Complicated with Ventricular Tachycardia

ISOSORBIDE DINITRATE

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Heart Failure. Dr. Alia Shatanawi

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

Metoprolol Succinate SelokenZOC

Transcription:

Angina Pectoris Dr. Syed 1

What is Angina Pectoris (AP)? Commonly known as angina is chest pain often due to ischemia of the heart muscle, Because of obstruction or spasm of the coronary arteries 2

What causes AP? Primary cause: Shortage of oxygen supplied by coronary arteries Oxygen deficiency leads to Ischemia (Medical term for what happens when your heart muscle doesn't get enough oxygen) Resulting Ischemia leads to pain 3

Types of AP AP Occurs when heart Oxygen requirement exceeds supply during stress Mostly due to obstruction of coronary disease Effort Angina Unstable Angina Occurs at rest Caused by major block in coronary artery caused by platelets around plaque High risk of myocardial infarction 4

How to treat AP?? Decrease Oxygen Demand Increase Oxygen Delivery Effort Angina: Oxygen demand can be decreased by decreasing cardiac work In unstable angina, vigorous measures of both decreasing O 2 demand, decreasing cardiac work 5

Drug Class to treat AP Vasodilators Ca- channel Blockers Beta-blockers These drugs decrease myocardial oxygen requirement by decreasing 1. Heart rate 2. Ventricular volume 3. Blood pressure 4. contractility 6

Organic Nitrates (Vasodilators) Simple nitric and nitrous acid esters of polyalcohol Nitroglycerin : prototype Isosorbide dintrate Nitroglycerine Amyl nitrate 7

Pharmacokinetics of Nitrates Liver rapidly metabolizes nitrates (Active reductases removing nitrate group) Oral bioavailability is low (10 20 %) Sub-lingual route preferred as it avoids first-pass effect Rapidly absorbed, effect in minutes When larger dose, other administration routes (sustained release oral, buccal) 8

First Pass Effect Sublingual or buccal routes by passes Liver & deliver drug directly to blood circulation 9

Pharmacodynamic Effect of Nitrates In general these drugs have to be bio-activated to release nitric oxide (NO) Nitro-glycerin Glutathione s transferase ALDH2 or ALDH3 Nitric Oxide 10

Effect of Nitrates on Vascular Smooth Muscle All vascular segments (Arteries/Veins) relax in response Veins respond to lower conc compared to arteries Primary effect: Relaxation of veins with increased venous capacity & lower ventricular pre-load As a result, pulmonary vascular pressure and heart size reduced Some studies suggest nitroglycerin redistributes coronary blood flow from normal to ischemic region 11

Clinical use of nitroglycerin Sub-lingual most frequently used agent in treatment of AP Duration of effect is short so cannot use as maintenance therapy IV use only in severe, recurrent rest angina Slower release formulations developed (buccal, oral ) but risk developing tolerance 12

Toxicity of Nitroglycerin Acute adverse effect are direct extension on vasodilation Orthostatic hypotension Tachycardia Throbbing headache 13

Calcium channel blockers Drugs bind to Calcium channel, prevent movement of calcium Calcium is important for heart muscle, smooth muscle contraction Results in vasodilation (smooth muscle relaxation) Reduction in heart contractility, decrease AV node activity 14

Calcium Channel Blockers Verapamil Nifedipine Diltiazem Verapamil, first clinically useful member Nifedipine, prototype of dihydro-pyridine class These drugs have high first pass, plasma binding, extensive metabolism 15

Pharmacodynamic effect Vascular Smooth Muscle: Most smooth muscle depend on Calcium Blockers relax muscle cells Blood pressure is reduced Reduction in resistance helps in Effort Angina Cardiac Muscle: Cardiac muscle heavily depend on calcium for contraction Impulse generation Blockers block both effect Leads to reduction in cardiac mechanical function 16

Clinical Effect of Calcium channel blockers Calcium channel blockers Decrease myocardial contractile force, reduces heart oxygen requirement Decrease in arterial, venous pressure As a result Ventricular wall stress decreases - lower Oxygen requirement Decreased heart rate lower Oxygen requirement 17

Clinical use of Calcium channel blockers Use of particular Calcium channel blocker based on pharmacology & potential for adverse event Nifedipine has no effect on AV conduction so safer than verapamil, diltiazem Contraindicated in presence of heart failure Verapamil, diltiazem better tolerated in patients with low bp Unstable angina patients- immediate release Ca channel blockers might increase risk for AE 18

Toxicity of Calcium channel blockers Most important toxic effects are direct extension of their therapeutic effect Excessive inhibition of Calcium influx can cause Serious cardiac depression Bradycardia Anterioventricular block Cardiac arrest Heart failure 19

β -blockers Beta blockers block the effect of sympathetic nervous system on heart Beta blockers prevent binding of catecholamines (adrenaline) on beta receptors (β1) on heart 1. Resulting is slow heart rate 2. Decreased contractility of heart 20

β -blockers Lowering of heart rate, contractility reduces O 2 consumption of heart Most important factor in relief during AP Non-selective β -blockers: Carvedilol Nebivolol Selective β -blockers: Bisoprolol, metaprolol 21